Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.

Lim, Ka Keat

Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. [electronic resource] - Applied health economics and health policy 06 2018 - 395-406 p. digital

Publication Type: Journal Article

1179-1896

10.1007/s40258-018-0384-8 doi


Breast Neoplasms--diagnosis
Cost-Benefit Analysis
Developed Countries
Early Detection of Cancer
Female
Genes, BRCA1
Genetic Testing--economics
Humans
Likelihood Functions
Markov Chains
Mutation--genetics
Quality-Adjusted Life Years
Sensitivity and Specificity